{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:31:53Z","timestamp":1761708713802,"version":"3.28.2"},"reference-count":43,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.3201\/eid1211.060618","type":"journal-article","created":{"date-parts":[[2011,11,2]],"date-time":"2011-11-02T13:53:39Z","timestamp":1320242019000},"page":"1631-1637","source":"Crossref","is-referenced-by-count":48,"title":["Prophylaxis and Treatment of Pregnant Women for Emerging Infections and Bioterrorism Emergencies"],"prefix":"10.3201","volume":"12","author":[{"given":"Joanne","family":"Cono","sequence":"first","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet D.","family":"Cragan","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise J.","family":"Jamieson","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja A.","family":"Rasmussen","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid1211.060618-202408141201-R1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0733-8627(01)00006-2","article-title":"Medical management of vulnerable populations and co-morbid conditions of bioterrorism.","volume":"20","author":"White","year":"2002","journal-title":"Emerg Med Clin North Am"},{"key":"key-10.3201\/eid1211.060618-202408141201-R2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2307\/2991522","article-title":"Unintended pregnancy in the United States.","volume":"30","author":"Henshaw","year":"1998","journal-title":"Fam Plann Perspect"},{"key":"key-10.3201\/eid1211.060618-202408141201-R3","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/S0029-7844(98)00444-X","article-title":"Pharmacokinetics during pregnancy: evidence-based maternal dose formulation.","volume":"93","author":"Little","year":"1999","journal-title":"Obstet Gynecol"},{"doi-asserted-by":"crossref","unstructured":"Uhl K. Conducting clinical pharmacology studies in pregnant and lactating women. In: Sahajwalla CG, editor. New drug development: regulatory paradigms for clinical pharmacology and biopharmaceutics. New York: Marcel Dekker, Inc.; 2004. p. 267\u201396.","key":"key-10.3201\/eid1211.060618-202408141201-R4","DOI":"10.1201\/9780203026427.ch13"},{"unstructured":"Scott JR, Gibbs RS, Karlan BY, Haney AF. Danforth's obstetrics and gynecology. 9th ed. Philadelphia: Williams and Wilkins; 2003. p. 280.","key":"key-10.3201\/eid1211.060618-202408141201-R5"},{"key":"key-10.3201\/eid1211.060618-202408141201-R6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00005721-200511000-00015","article-title":"Medications in pregnancy and lactation.","volume":"30","author":"McCarter-Spaulding","year":"2005","journal-title":"MCN Am J Matern Child Nurs"},{"key":"key-10.3201\/eid1211.060618-202408141201-R7","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2165\/00003088-199733050-00002","article-title":"Pharmacokinetic changes during pregnancy and their clinical relevance.","volume":"33","author":"Loebstein","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"key-10.3201\/eid1211.060618-202408141201-R8","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3201\/eid1211.060152","article-title":"Emerging infections and pregnancy.","volume":"12","author":"Jamieson","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid1211.060618-202408141201-R9","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1067\/mob.2002.128027","article-title":"The obstetrician-gynecologist's role in adult immunization.","volume":"187","author":"Gonik","year":"2002","journal-title":"Am J Obstet Gynecol"},{"unstructured":"Moore KL, Persaud TV. The developing human: clinically oriented embryology. 7th ed. Philadelphia: W.B. Saunders; 2003.","key":"key-10.3201\/eid1211.060618-202408141201-R10"},{"key":"key-10.3201\/eid1211.060618-202408141201-R11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0027-5107(97)00178-4","article-title":"Developmental toxicity induced during early stages of mammalian embryogenesis.","volume":"396","author":"Rutledge","year":"1997","journal-title":"Mutat Res"},{"unstructured":"Jones KL. Smith's recognizable patterns of human malformation. 5th ed. Philadelphia: W.B. Saunders; 1997. p. 1\u20137.","key":"key-10.3201\/eid1211.060618-202408141201-R12"},{"unstructured":"Friedman JM, Polifka JE. Teratogenic effects of drugs: a resource for clinicians (TERIS). 2nd ed. Baltimore: Johns Hopkins University Press; 2000.","key":"key-10.3201\/eid1211.060618-202408141201-R13"},{"key":"key-10.3201\/eid1211.060618-202408141201-R14","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1542\/peds.113.S3.984","article-title":"Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents).","volume":"113","author":"Brent","year":"2004","journal-title":"Pediatrics"},{"key":"key-10.3201\/eid1211.060618-202408141201-R15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1089\/jwh.2005.14.104","article-title":"Medication use in pregnancy and lactation: an urgent call for public health action.","volume":"14","author":"Lagoy","year":"2005","journal-title":"J Womens Health (Larchmt)"},{"key":"key-10.3201\/eid1211.060618-202408141201-R16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0029-7844(02)02122-1","article-title":"Teratogenicity of recently introduced medications in human pregnancy.","volume":"100","author":"Lo","year":"2002","journal-title":"Obstet Gynecol"},{"unstructured":"Food and Drug Administration. 21 CFR 201.57 use-in-pregnancy rating system. 1979 [cited 2006 Feb 13]. Available from http:\/\/a257.g.akamaitech.net\/7\/257\/2422\/04nov20031500\/edocket.access.gpo.gov\/cfr_2001\/aprqtr\/21cfr201.57.htm","key":"key-10.3201\/eid1211.060618-202408141201-R17"},{"key":"key-10.3201\/eid1211.060618-202408141201-R18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1067\/mob.2002.125740","article-title":"Review of pregnancy labeling of prescription drugs: is the current system adequate to inform of risks?","volume":"187","author":"Doering","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.3201\/eid1211.060618-202408141201-R19","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1345\/aph.1A034","article-title":"FDA labeling system for drugs in pregnancy.","volume":"35","author":"Boothby","year":"2001","journal-title":"Ann Pharmacother"},{"unstructured":"Uhl K, Kennedy DL, Kweder SL. Information on medication use in pregnancy. Am Fam Physician. 2003;67:2476, 2478.","key":"key-10.3201\/eid1211.060618-202408141201-R20"},{"key":"key-10.3201\/eid1211.060618-202408141201-R21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0301-2115(00)00375-4","article-title":"Perception of teratogenic risk of common medicines.","volume":"95","author":"Sanz","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key-10.3201\/eid1211.060618-202408141201-R22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1159\/000078174","article-title":"SARS in newborns and children.","volume":"85","author":"Ng","year":"2004","journal-title":"Biol Neonate"},{"key":"key-10.3201\/eid1211.060618-202408141201-R23","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1471-0528.2004.00199.x","article-title":"A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome.","volume":"111","author":"Lam","year":"2004","journal-title":"BJOG"},{"key":"key-10.3201\/eid1211.060618-202408141201-R24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10096-005-0004-z","article-title":"Treatment of severe acute respiratory syndrome.","volume":"24","author":"Lai","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key-10.3201\/eid1211.060618-202408141201-R25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/bdra.10020","article-title":"Developmental toxicity of ribavirin\/IFalpha combination therapy: is the label more dangerous than the drugs?","volume":"67","author":"Polifka","year":"2003","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"key-10.3201\/eid1211.060618-202408141201-R26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","article-title":"Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies.","volume":"62","author":"Park-Wyllie","year":"2000","journal-title":"Teratology"},{"key":"key-10.3201\/eid1211.060618-202408141201-R27","first-page":"642","article-title":"Update: multistate outbreak of monkeypox\u2014Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003.","volume":"52","author":"Centers for Disease Control and Prevention","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1211.060618-202408141201-R28","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/ije\/17.3.643","article-title":"The transmission potential of monkeypox virus in human populations.","volume":"17","author":"Fine","year":"1988","journal-title":"Int J Epidemiol"},{"unstructured":"Centers for Disease Control and Prevention. Updated interim CDC guidance for use of smallpox vaccine, cidofovir, and vaccinia immune globulin (VIG) for prevention and treatment in the setting of an outbreak of monkeypox infections. June 25, 2003. [cited 2006 Sep 13]. Available from http:\/\/www.cdc.gov\/ncidod\/monkeypox\/treatmentguidelines.htm","key":"key-10.3201\/eid1211.060618-202408141201-R29"},{"key":"key-10.3201\/eid1211.060618-202408141201-R30","first-page":"1","article-title":"Smallpox vaccination and adverse reactions. Guidance for clinicians.","volume":"52","author":"Cono","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid1211.060618-202408141201-R31","first-page":"1","article-title":"Recommendations for using smallpox vaccine in a pre-event vaccination program: supplemental recommendations of the Advisory Committee on Immunization Practices and the Healthcare Infection Control Practices Advisory Committee.","volume":"52","author":"Wharton","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid1211.060618-202408141201-R32","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1097\/01.AOG.0000114987.76424.6d","article-title":"The role of the obstetrician-gynecologist in emerging infectious diseases: monkeypox and pregnancy.","volume":"103","author":"Jamieson","year":"2004","journal-title":"Obstet Gynecol"},{"key":"key-10.3201\/eid1211.060618-202408141201-R33","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.2105\/AJPH.2004.054957","article-title":"Public health approach to emerging infections among pregnant women.","volume":"95","author":"Rasmussen","year":"2005","journal-title":"Am J Public Health"},{"key":"key-10.3201\/eid1211.060618-202408141201-R34","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.clp.2005.04.009","article-title":"Influenza and pneumonia in pregnancy.","volume":"32","author":"Laibl","year":"2005","journal-title":"Clin Perinatol"},{"key":"key-10.3201\/eid1211.060618-202408141201-R35","first-page":"1","article-title":"Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"54","author":"Harper","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid1211.060618-202408141201-R36","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1056\/NEJMp058276","article-title":"Influenza: interpandemic as well as pandemic disease.","volume":"353","author":"Dolin","year":"2005","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid1211.060618-202408141201-R37","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1001\/jama.287.17.2236","article-title":"Anthrax as a biological weapon, 2002: updated recommendations for management.","volume":"287","author":"Inglesby","year":"2002","journal-title":"JAMA"},{"key":"key-10.3201\/eid1211.060618-202408141201-R38","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1097\/01.inf.0000101994.25947.12","article-title":"Safety profile of quinolone antibiotics in the pediatric population.","volume":"22","author":"Grady","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid1211.060618-202408141201-R39","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1542\/peds.113.S3.1120","article-title":"Teeth.","volume":"113","author":"Billings","year":"2004","journal-title":"Pediatrics"},{"key":"key-10.3201\/eid1211.060618-202408141201-R40","first-page":"960","article-title":"Updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis.","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1211.060618-202408141201-R41","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0020-7292(02)90062-7","article-title":"Management of asymptomatic pregnant or lactating women exposed to anthrax.","volume":"77","author":"ACOG Committee on Obstetric Practice","year":"2002","journal-title":"Int J Gynaecol Obstet"},{"unstructured":"Ryan M, Aran R, Campbell K, Chow S, Conlin A, Strickler J,  The national smallpox vaccine in pregnancy registry: update on women inadvertently exposed to smallpox vaccine and their early pregnancy outcomes. NCBDDD conference program book; 2004.[cited 2006 Feb 13]. Available from http:\/\/www.cdc.gov\/ncbddd\/conference\/NCBDDD%20Program%20Book.pdf","key":"key-10.3201\/eid1211.060618-202408141201-R42"},{"unstructured":"Department of Defense Birth and Infant Health Registry. Naval Health Research Center Web site. [cited 2006 May 1]. Available from http:\/\/www.nhrc.navy.mil\/rsch\/code25\/projects\/birthdefects.htmTABLES 1-2 \u2013 see separate documents","key":"key-10.3201\/eid1211.060618-202408141201-R43"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/12\/11\/06-0618_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T14:16:38Z","timestamp":1732630598000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/12\/11\/06-0618_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11]]}},"URL":"https:\/\/doi.org\/10.3201\/eid1211.060618","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"type":"print","value":"1080-6040"},{"type":"electronic","value":"1080-6059"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}